Paul Wicks is a scientific advisor for digital health company Ada Health. At Ada, Paul works on strategy, rare diseases and scientific communications. A rare diseases expert, Paul is a neuropsychologist and independent consultant for digital health, clinical trials, and patient centricity. Previously, he spent 13 years leading the R&D team at PatientsLikeMe, an online community for over 700,...
South Korea’s AI-based medical analysis solutions company, JLK Inspection, announced the recent signing of an agreement with the Clinton Health Access Initiative (CHAI) in Lao PDR, a US based INGO to support the Lao PDR National TB Center (NTC) in strengthening and expanding access to tuberculosis screening via AI enabled CXR reading.
CHAI is a global health organization committed to saving lives...
Since the outbreak of COVID-19 virus in China, Shanghai Public Health Clinical Center (SPHCC) has been actively mobilizing other parties to use the latest tech in the fight against the virus. Through the joint effort of SPHCC and Yitu Healthcare, a Shanghai-based AI startup, the Intelligent Evaluation System of Chest CT for COVID-19 was officially launched on 28 January.
HOW IT WORKS
The system...
Integrated Health Information Systems (IHiS), the national HIT agency in Singapore, has partnered with local healthcare AI startup KroniKare to pilot iThermo – an AI-powered temperature screening solution that screens and identifies those having or showing symptoms of fever. iThermo is currently being piloted at IHiS headquarters in Serangoon North and St. Andrews Community Hospital (SACH) from...
A study published in Nature has demonstrated how artificial intelligence (AI) research can drive and accelerate new scientific discoveries.
Alphabet subsidiary DeepMind has created a dedicated, interdisciplinary team to explore using AI to predict the 3D structure of a protein based solely on its genetic sequence.
Its system, AlphaFold, builds on prior research using large genomic datasets to...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
Google’s artificial intelligence proved more accurate in identifying breast cancer from mammograms than doctors, according to a study published in Nature yesterday.
The initial results of Google’s AI for breast cancer screening, found that the system was able to reduce the number of both false positives and false negatives in breast cancer detection. The study was born out of a collaboration...
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
